Cancer Diagnostics Firm Nucleix Plans European Market Expansion
Cancer diagnostics company Nucleix is planning to scale up commercial activities in Europe for its bladder test Bladder EpiCheck. The Israeli firm told Medtech Insight it is currently in advanced negotiations with distributors to expand the test's commercial reach.
You may also be interested in...
Experts from the University of Chicago are advocating for helmet ventilation for COVID-19 patients. Medtech Insight spoke to acute nurse practitioner Aurika Savickaite who is helping lead an initiative to educate and raise awareness of the technology.
Belgian start-up miDiagnostics has closed a €14m investment round to accelerate development of its silicon-chip-based diagnostics platform. The company believes the blood analyzer could deliver rapid test results in multiple settings.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.